The Cut-Off Level of Recombinant Human TSH-Stimulated Thyroglobulin in the Follow-Up of Patients with Differentiated Thyroid Cancer

BACKGROUND: The treatment of differentiated thyroid cancer (DTC) ends in full recovery in 80% of cases. However, in 20% of cases local recurrences or distant metastases are observed, for this reason DTC patients are under life-long follow-up. The most sensitive marker for recurrence is stimulated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalska, Aldona, Pałyga, Iwona, Gąsior-Perczak, Danuta, Walczyk, Agnieszka, Trybek, Tomasz, Słuszniak, Anna, Mężyk, Ryszard, Góźdź, Stanisław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521804/
https://www.ncbi.nlm.nih.gov/pubmed/26230494
http://dx.doi.org/10.1371/journal.pone.0133852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521804/
https://www.ncbi.nlm.nih.gov/pubmed/26230494
http://dx.doi.org/10.1371/journal.pone.0133852

Ejemplares similares